Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma

BMI-1 过度表达促进骨肉瘤细胞生长和对顺铂治疗的耐药性

阅读:14
作者:Zhihong Wu, Li Min, Dafu Chen, Dongsheng Hao, Yuanhui Duan, Guixing Qiu, Yipeng Wang

Background

BMI-1 is a member of the polycomb group of genes (PcGs), and it has been implicated in the development and progression of several malignancies, but its role in osteosarcoma remains to be elucidated. Methodology/principal findings: In the present study, we found that BMI-1 was overexpressed in different types of osteosarcomas. Downregulation of BMI-1 by lentivirus mediated RNA interference (RNAi) significantly impaired cell viability and colony formation in vitro and tumorigenesis in vivo of osteosarcoma cells. BMI-1 knockdown sensitized cells to cisplatin-induced apoptosis through inhibition of PI3K/AKT pathway. Moreover, BMI-1-depletion-induced phenotype could be rescued by forced expression of BMI-1 wobble mutant which is resistant to inhibition by the small interfering RNA (siRNA). Conclusions/significance: These findings suggest a crucial role for BMI-1 in osteosarcoma pathogenesis.

Significance

These findings suggest a crucial role for BMI-1 in osteosarcoma pathogenesis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。